Dementia Dx Firm Cytox Raises $2.5M | GenomeWeb

NEW YORK (GenomeWeb News) – Dementia diagnostics firm Cytox today said that it raised £1.5 million ($2.5 million) in a second round of funding.

The financing was led by existing investor Spark Impact, manager of The North West Fund for Biomedical. Other existing investors, including Wren Capital, the Rainbow Seed Fund, and private investors also participated in the round, as did new investor Seneca Partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.